The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon-like peptide-1 receptor agonist therapy
These may include arteriosclerosis (hardening of the arteries), symptomatic cardiovascular disease, moderate to severe hypertension (high blood pressure), hyperthyroidism (overactive thyroid), psychiatric issues, or known hypersensitivity or idiosyncrasy to amphetamines
providers who can prescribe compounded semaglutide, which is then prepared by U.S.-based compounding pharmacies and shipped domestically
Previous weight loss attempts, insulin resistance patterns, and inflammation levels all contribute to how quickly and substantially your body sheds pounds during treatment
While rare complications like gastroparesis (stomach paralysis) or pancreatitis can occur, they are uncommon